Literature DB >> 21385443

Prevalence and severity of antipsychotic related constipation in patients with schizophrenia: a retrospective descriptive study.

Marc De Hert1, Liesbeth Dockx, Chiara Bernagie, Bie Peuskens, Kim Sweers, Stefan Leucht, Jan Tack, Stefan Van de Straete, Martien Wampers, Joseph Peuskens.   

Abstract

BACKGROUND: Antipsychotic are the cornerstone in the treatment of schizophrenia. They also have a number of side-effects. Constipation is thought to be common, and a potential serious side-effect, which has received little attention in recent literature.
METHOD: We performed a retrospective study in consecutively admitted patients, between 2007 and 2009 and treated with antipsychotic medication, linking different electronic patient data to evaluate the prevalence and severity of constipation in patients with schizophrenia under routine treatment conditions.
RESULTS: Over a period of 22 months 36.3% of patients (99) received at least once a pharmacological treatment for constipation. On average medication for constipation was prescribed for 273 days. Severe cases (N = 50), non-responsive to initial treatment, got a plain x-ray of the abdomen. In 68.4% fecal impaction was found.
CONCLUSION: A high prevalence of constipation, often severe and needing medical interventions, was confirmed during the study period. Early detection, monitoring over treatment and early intervention of constipation could prevent serious consequences such as ileus.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21385443      PMCID: PMC3062582          DOI: 10.1186/1471-230X-11-17

Source DB:  PubMed          Journal:  BMC Gastroenterol        ISSN: 1471-230X            Impact factor:   3.067


  21 in total

Review 1.  Death from clozapine-induced constipation: case report and literature review.

Authors:  Tomer T Levin; Jonathan Barrett; Alan Mendelowitz
Journal:  Psychosomatics       Date:  2002 Jan-Feb       Impact factor: 2.386

2.  Clozapine in China: a review and preview of US/PRC collaboration.

Authors:  W Z Potter; G N Ko; L D Zhang; W W Yan
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

3.  Objective evaluation of pain perception in patients with schizophrenia.

Authors:  R Guieu; J C Samuélian; H Coulouvrat
Journal:  Br J Psychiatry       Date:  1994-02       Impact factor: 9.319

4.  Clozapine-induced constipation.

Authors:  G Hayes; B Gibler
Journal:  Am J Psychiatry       Date:  1995-02       Impact factor: 18.112

5.  Risk factors for ileus in patients with schizophrenia.

Authors:  Jimmi Nielsen; Jonathan M Meyer
Journal:  Schizophr Bull       Date:  2010-11-26       Impact factor: 9.306

Review 6.  The health-related quality of life and economic burden of constipation.

Authors:  Cheryl Dennison; Manishi Prasad; Andrew Lloyd; Samir K Bhattacharyya; Ravinder Dhawan; Karin Coyne
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

Review 7.  Pain insensitivity in schizophrenia: a neglected phenomenon and some implications.

Authors:  R H Dworkin
Journal:  Schizophr Bull       Date:  1994       Impact factor: 9.306

Review 8.  Physical illness and schizophrenia: a review of the literature.

Authors:  S Leucht; T Burkard; J Henderson; M Maj; N Sartorius
Journal:  Acta Psychiatr Scand       Date:  2007-11       Impact factor: 6.392

Review 9.  Physical health monitoring of patients with schizophrenia.

Authors:  Stephen R Marder; Susan M Essock; Alexander L Miller; Robert W Buchanan; Daniel E Casey; John M Davis; John M Kane; Jeffrey A Lieberman; Nina R Schooler; Nancy Covell; Scott Stroup; Ellen M Weissman; Donna A Wirshing; Catherine S Hall; Leonard Pogach; Xavier Pi-Sunyer; J Thomas Bigger; Alan Friedman; David Kleinberg; Steven J Yevich; Bonnie Davis; Steven Shon
Journal:  Am J Psychiatry       Date:  2004-08       Impact factor: 18.112

10.  Risk factors for chronic constipation based on a general practice sample.

Authors:  Nicholas J Talley; Michael Jones; Guy Nuyts; Dominique Dubois
Journal:  Am J Gastroenterol       Date:  2003-05       Impact factor: 10.864

View more
  20 in total

1.  The impact of opiate pain medications and psychoactive drugs on the quality of colon preparation in outpatient colonoscopy.

Authors:  Vladimir M Kushnir; Pavan Bhat; Reena V Chokshi; Alexander Lee; Brian B Borg; Chandra Prakash Gyawali; Gregory S Sayuk
Journal:  Dig Liver Dis       Date:  2013-09-06       Impact factor: 4.088

Review 2.  Drug-induced gastrointestinal disorders.

Authors:  H L Philpott; S Nandurkar; J Lubel; P R Gibson
Journal:  Frontline Gastroenterol       Date:  2013-06-19

Review 3.  Gastroenterology issues in schizophrenia: why the gut matters.

Authors:  Emily G Severance; Emese Prandovszky; James Castiglione; Robert H Yolken
Journal:  Curr Psychiatry Rep       Date:  2015-05       Impact factor: 5.285

4.  Colonic architectural change on colonoscopy in patients taking psychotropic medications.

Authors:  Eu Jin Tan; Keng Chuan Soh; Kee Yuan Ngiam
Journal:  Surg Endosc       Date:  2012-10-18       Impact factor: 4.584

5.  Effect of probiotic supplementation on schizophrenia symptoms and association with gastrointestinal functioning: a randomized, placebo-controlled trial.

Authors:  Faith B Dickerson; Cassie Stallings; Andrea Origoni; Emily Katsafanas; Christina L G Savage; Lucy A B Schweinfurth; Joshana Goga; Sunil Khushalani; Robert H Yolken
Journal:  Prim Care Companion CNS Disord       Date:  2014-02-13

6.  Factors predicting use of laxatives in outpatients stabilized on clozapine.

Authors:  Loren Bailey; Seema Varma; Nina Ahmad; Siobhan Gee; David M Taylor
Journal:  Ther Adv Psychopharmacol       Date:  2015-10

7.  Non-motor symptoms in Huntington's disease: a comparative study with Parkinson's disease.

Authors:  Tatiana Aldaz; Pasquale Nigro; Almudena Sánchez-Gómez; Celia Painous; Lluís Planellas; Pilar Santacruz; Ana Cámara; Yaroslau Compta; Francesc Valldeoriola; Maria J Martí; Esteban Muñoz
Journal:  J Neurol       Date:  2019-03-05       Impact factor: 4.849

8.  The Effects of Probiotic and Selenium Co-supplementation on Clinical and Metabolic Scales in Chronic Schizophrenia: a Randomized, Double-blind, Placebo-Controlled Trial.

Authors:  Hamidreza Jamilian; Amir Ghaderi
Journal:  Biol Trace Elem Res       Date:  2021-01-06       Impact factor: 3.738

Review 9.  Antipsychotic-Induced Constipation: A Review of the Pathogenesis, Clinical Diagnosis, and Treatment.

Authors:  Yue Xu; Nousayhah Amdanee; Xiangrong Zhang
Journal:  CNS Drugs       Date:  2021-08-24       Impact factor: 5.749

10.  Self-administered acupressure for treating adult psychiatric patients with constipation: a randomized controlled trial.

Authors:  Wai Kit Wong; Wai Tong Chien; Wai Ming Lee
Journal:  Chin Med       Date:  2015-11-03       Impact factor: 5.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.